A senior vice president at a global healthcare company once put together a rigorous business case for a diagnostic platform targeting cardiovascular disease in women. The science was promising. The market was real. She presented the whole thing to leadership, and when the financial model hit the screen, the CFO didn’t hesitate: “Market too small. Let’s cut it.”

The few women in the room were stunned. Nobody challenged the assumption. Nobody questioned the model. And nobody paused to ask whether the numbers reflected reality. The unmet market they dismissed wasn’t small. It was half the population.

I’ve watched that pattern play out in dozens of boardrooms. Someone raises women’s health, and the room quietly categorizes it as a “benefit,” a “DEI initiative,” or worse, a “nice-to-have.” Eyes glaze. The conversation drifts back to revenue, margin, and growth.

That reaction isn’t malicious. It’s structural. Women’s health has been framed incorrectly for decades.

But for the people who know the business case, reactions like that cause our eyes to roll, our blood to boil, and our confidence in the leadership to be questioned.

If leaders want people to stay engaged, they need to stop talking about women’s health as a moral argument and start talking about it as a business strategy. The companies that get this right aren’t doing it because it feels good. They’re doing it because the numbers are clear.

Lead with the Business Case 

From personal experience, this is the fastest area of improvement for anyone talking about women’s health, and I’ve seen the shift happen in minutes when reframed. If you open with a personal story about menopause or fertility struggles, you’ll lose half the room. Not because those stories aren’t valid, but because executives are trained to listen for financial impact.

Instead, articulate the operational implications.

  • Retention: Replacing a mid-career employee can cost 1.5 to 2 times their annual salary. Women in their late 30s to early 50s are often at peak productivity and leadership trajectory. They’re also navigating fertility treatments, pregnancy, postpartum recovery, perimenopause, and caregiving responsibilities. If unmanaged or unsupported, these health transitions drive attrition. 
  • Absenteeism and presenteeism: Chronic conditions that disproportionately affect women, including autoimmune disorders, migraines, endometriosis, and cardiovascular disease, are not fringe issues. They reduce output and increase short-term disability claims. Ignoring them doesn’t make them disappear; it embeds inefficiency into your operating model. 
  • Healthcare costs: Delayed diagnosis in women, particularly in areas like heart disease and oncology, increases downstream costs. Preventive investment isn’t a social gesture. It’s cost containment. 
  • Loyalty: Companies that address women’s health in a structured way signal long-term thinking. That attracts talent. It also reduces the silent churn of high performers who simply choose to leave environments that make their health invisible.

If the conversation is framed around these metrics, the room will stay engaged.

Be Specific

Saying “we should care about women’s health” is not a strategy. It’s a sentiment. It’s advocacy.

Anchor the discussion in your company’s specific context, with the business case leading. I promise, it makes a difference.

If you’re in manufacturing, talk about how ergonomic design and shift flexibility reduce musculoskeletal strain for pregnant workers and decrease workers’ compensation claims. If you’re in tech, discuss how inclusive health benefits improve retention in competitive hiring markets, and ensure that your tech is trained with women’s data, as that will ensure better compliance and retention in the long term. If you’re in healthcare or medtech, outline the revenue opportunity in addressing historically underdiagnosed populations. Women’s health is a growth sector and should be framed as such.

Specificity communicates seriousness. It also prevents the topic from being dismissed as ideological.

Avoid Overstatement

The business case for women’s health is already strong. It doesn’t need exaggeration. But be prepared with numbers.

Not every initiative will double profits. Not every investment will produce immediate ROI. Overpromising undermines credibility. Instead, present measured expectations. Improved retention by even a few percentage points can have significant financial impact. Reduced healthcare claims over time improve margins. Higher engagement scores correlate with productivity and loyalty.

This is long-term value creation, not a quarterly earnings tactic. When leaders stay factual and grounded, they’re harder to dismiss.

Integrate

One of the fastest ways to lose an audience is to position women’s health as a separate program disconnected from core strategy. It should be integrated into talent strategy, product design, risk management, and growth planning.

Include women’s health benefits in total rewards planning, not as an add-on but as a lever for workforce stability. If your customers are women, or influenced by women, ensure your product roadmap reflects their health realities. Recognize that ignoring health disparities creates long-term financial and reputational risk. And understand that women control significant consumer spending; companies that understand their health priorities build stronger brand trust.

When women’s health is woven into these pillars, it stops being a “side conversation.”

Make It About Performance, Not Accommodation.

The most effective framing is simple: healthy employees perform better. Healthy customers buy more consistently. Healthy communities sustain markets. Women’s health affects all three.

Consider the mid-career leader managing a global team while navigating untreated perimenopause symptoms. Cognitive fog, sleep disruption, and anxiety are not character flaws. They are physiological realities. Addressing them through benefits, flexibility, and education isn’t accommodation. It’s performance optimization.

Many executives were trained in environments where discussing menopause, miscarriage, or menstrual health was considered unprofessional. I’ve seen this be especially relevant across cultures, including in Asia and Africa. Expecting immediate fluency is unrealistic, but the solution isn’t to force vulnerability. It’s to normalize data-driven discussion. You can acknowledge that these topics were historically private while making clear that they have economic implications. That balance keeps the conversation mature.

Personal stories have a place, but they should reinforce the strategy, not replace it. A brief, well-placed example of talent lost or productivity gained can humanize the numbers. The key is proportion.

Shift from Permission to Expectation

Finally, stop asking for permission to discuss women’s health. It’s not a favor to women. It’s responsible management. If I hear the words “I’m sorry for bringing this up” before discussing a women’s health innovation or initiative again, I might pull out all of my hair.

The companies that treat women’s health as infrastructure, essential to workforce stability and economic growth, will outperform those that treat it as a cultural trend. The broader market is already moving. Investors are paying closer attention to healthcare efficiency and workforce resilience. Governments are examining the economic drag of untreated health conditions. Consumers are demanding transparency.

Silence is no longer neutral. It signals strategic blind spots.

Talking about women’s health at work doesn’t require emotional appeals or sweeping rhetoric. It requires clarity, data, and alignment with business priorities. Lead with the numbers. Tie it to performance. Be specific about impact. Stay factual.

When framed correctly, no one tunes out, because they recognize it for what it is: not a side issue, but a driver of sustainable growth.